Characterization of the Use of Antipsychotics in PTSD During the Past Seven Years

Completed

Conditions studied: PTSD, Post-Traumatic Stress Disorder

In brief

The primary objective is to examine the percentage of patients with PTSD who were prescribed an antipsychotic over the past seven years in the VA Network 7 (AL, GA, SC) and compare the percentage on an annual basis. We will also determine the type and dose of antipsychotics received. We hypothesize that there has been a significant increase in antipsychotic use, especially atypical antipsychotics, prescribed for patients with PTSD over the last 7 years

Key facts

Study ID

NCT00230893

Run by

Tuscaloosa Research & Education Advancement Corporation

People needed

99

Starts

2005-07-01

Expected to finish

2005-09-01

Last updated by the study team

2006-09-21

Who can join

Age: 19 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Male or female patients, any race or ethnic origin at least 19 years of age.
• Patients with a diagnosis of PTSD
• Treated with an antipsychotic as a monotherapy or adjunctive therapy
• Patient must have been seen at a VA medical center or clinic within VISN 7 during the study period.

You may not qualify if…

• Patients not diagnosed with PTSD
• Not treated with an antipsychotic as a monotherapy or adjunctive therapy
• Patients outside of Network 7
• Patients with a diagnosis of schizophrenia, schizoaffective disorder, or bipolar disorder

Where it is running

• Tuscaloosa VA Medical Center — Tuscaloosa, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.